Over 2650 Total Lots Up For Auction at Four Locations - NY 11/30, MN 12/01, CA 12/03, UT 12/09

Providers, industry, patient stakeholders applaud introduction of Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2021

Press releases may be edited for formatting or style | July 21, 2021 Molecular Imaging

"Passage of the FIND Act will give patients and their physicians the tools they need to diagnose life-threatening diseases sooner- when they are most treatable," said Rep. Murphy. "Already, we've seen that nuclear medicine has the potential to play a larger role in diagnosing advanced disease, including prostate and breast cancer. By finding and confirming these diseases earlier we can not only reduce downstream costs but more importantly, save lives."

"The FIND Act represents a much needed, bi-partisan legislative solution that would modernize CMS payment policies for diagnostic radiopharmaceuticals and expand beneficiary access to diagnostic modalities that can improve outcomes and reduce downstream medical costs," said Sue Bunning, MITA Industry Director of Molecular Imaging & PET. "As an added benefit, the bill would also encourage innovators, product developers, and other stakeholders in the medical technology space to devote more resources towards the research and development of more advanced diagnostic technologies, yielding immeasurable benefits to future generations of patients."

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

Quest Imaging Solutions provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs



About MITA
MITA is the collective voice of manufacturers of medical imaging equipment, radiopharmaceuticals, contrast media, and focused ultrasound therapeutic devices. It represents companies whose sales comprise more than 90 percent of the global market for medical imaging innovations. These products include: magnetic resonance imaging (MRI), medical X-Ray equipment, computed tomography (CT) scanners, ultrasound, nuclear imaging, radiopharmaceuticals, and imaging information systems. MITA Member company technologies are an important part of our nation's healthcare infrastructure and are essential for the screening, diagnosis, staging, managing and effectively treating patients with cancer, heart disease, neurological degeneration, and numerous other medical conditions.

Back to HCB News

You Must Be Logged In To Post A Comment